Loading…

Delayed Functional Loss in Glaucoma LII Edward Jackson Memorial Lecture

This study is a systematic exploration of why some patients with glaucoma continue to lose visual field long after therapeutic normalization of their increased intraocular pressures. Three cases of glaucoma are described that had increased intraocular pressures and good initial visual fields. The fo...

Full description

Saved in:
Bibliographic Details
Published in:American journal of ophthalmology 1996-05, Vol.121 (5), p.473-483
Main Author: BRUBAKER, RICHARD F.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c455t-fdbbc6ddf5d639abe9d13ece5dba0e1a3134e39a7c364bb67df85e6a38f6dcd43
cites cdi_FETCH-LOGICAL-c455t-fdbbc6ddf5d639abe9d13ece5dba0e1a3134e39a7c364bb67df85e6a38f6dcd43
container_end_page 483
container_issue 5
container_start_page 473
container_title American journal of ophthalmology
container_volume 121
creator BRUBAKER, RICHARD F.
description This study is a systematic exploration of why some patients with glaucoma continue to lose visual field long after therapeutic normalization of their increased intraocular pressures. Three cases of glaucoma are described that had increased intraocular pressures and good initial visual fields. The following four hypotheses are offered to explain delayed functional loss in these patients: (1) A process independent of intraocular pressure is killing ganglion cells. (2) Unmeasured increases of pressure are killing ganglion cells. (3) The ganglion cells have a genetically determined hypersensitivity to intraocular pressure. (4) The ganglion cells have been rendered hypersensitive to intraocular pressure by irreversible damaging effects of previously increased intraocular pressures. The current state of knowledge does not permit the elimination of any of the four hypotheses. An additional hypothesis is that the final stage of ganglion cell death is mediated by apoptosis. If so, a potential new treatment for glaucoma would be to inhibit the apoptotic pathway.
doi_str_mv 10.1016/S0002-9394(14)75421-2
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78009214</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002939414754212</els_id><sourcerecordid>78009214</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-fdbbc6ddf5d639abe9d13ece5dba0e1a3134e39a7c364bb67df85e6a38f6dcd43</originalsourceid><addsrcrecordid>eNqFkE9LwzAYh4Moc04_wqAHET1UkyZN2pPI3Oak4kE9hzR5C9H-mUmr7NvbbmNXTy_h9_zyJg9CU4JvCSb87g1jHIUpTdk1YTciZhEJoyM0JolIQ5Kk5BiND8gpOvP-sz9ywcQIjRJOsEjxGC0foVQbMMGiq3Vrm1qVQdZ4H9g6WJaq002lgmy1CubmVzkTPCv95Zs6eIGqcXaAQbedg3N0UqjSw8V-TtDHYv4-ewqz1-Vq9pCFmsVxGxYmzzU3pogNp6nKITWEgobY5AoDUZRQBn0gNOUsz7kwRRIDVzQpuNGG0Qm62t27ds13B76VlfUaylLV0HReigTjNCIDGO9A7frvOCjk2tlKuY0kWA4C5VagHOxIwuRWoIz63nS_oMsrMIfW3lifX-5z5bUqC6dqbf0Bo1jQKIp77H6HQS_jx4KTXluoNRjremPSNPafh_wBXBSM4w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78009214</pqid></control><display><type>article</type><title>Delayed Functional Loss in Glaucoma LII Edward Jackson Memorial Lecture</title><source>ScienceDirect Freedom Collection</source><creator>BRUBAKER, RICHARD F.</creator><creatorcontrib>BRUBAKER, RICHARD F.</creatorcontrib><description>This study is a systematic exploration of why some patients with glaucoma continue to lose visual field long after therapeutic normalization of their increased intraocular pressures. Three cases of glaucoma are described that had increased intraocular pressures and good initial visual fields. The following four hypotheses are offered to explain delayed functional loss in these patients: (1) A process independent of intraocular pressure is killing ganglion cells. (2) Unmeasured increases of pressure are killing ganglion cells. (3) The ganglion cells have a genetically determined hypersensitivity to intraocular pressure. (4) The ganglion cells have been rendered hypersensitive to intraocular pressure by irreversible damaging effects of previously increased intraocular pressures. The current state of knowledge does not permit the elimination of any of the four hypotheses. An additional hypothesis is that the final stage of ganglion cell death is mediated by apoptosis. If so, a potential new treatment for glaucoma would be to inhibit the apoptotic pathway.</description><identifier>ISSN: 0002-9394</identifier><identifier>EISSN: 1879-1891</identifier><identifier>DOI: 10.1016/S0002-9394(14)75421-2</identifier><identifier>PMID: 8610790</identifier><identifier>CODEN: AJOPAA</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adult ; Apoptosis ; Awards and Prizes ; Biological and medical sciences ; Cell Death ; Female ; Glaucoma - pathology ; Glaucoma - physiopathology ; Glaucoma and intraocular pressure ; Humans ; Intraocular Pressure ; Male ; Medical sciences ; Middle Aged ; Ophthalmology ; Retinal Ganglion Cells - pathology ; Societies, Medical ; Vision Disorders - physiopathology ; Visual Fields - physiology</subject><ispartof>American journal of ophthalmology, 1996-05, Vol.121 (5), p.473-483</ispartof><rights>1996 Elsevier Inc.</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-fdbbc6ddf5d639abe9d13ece5dba0e1a3134e39a7c364bb67df85e6a38f6dcd43</citedby><cites>FETCH-LOGICAL-c455t-fdbbc6ddf5d639abe9d13ece5dba0e1a3134e39a7c364bb67df85e6a38f6dcd43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3073225$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8610790$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BRUBAKER, RICHARD F.</creatorcontrib><title>Delayed Functional Loss in Glaucoma LII Edward Jackson Memorial Lecture</title><title>American journal of ophthalmology</title><addtitle>Am J Ophthalmol</addtitle><description>This study is a systematic exploration of why some patients with glaucoma continue to lose visual field long after therapeutic normalization of their increased intraocular pressures. Three cases of glaucoma are described that had increased intraocular pressures and good initial visual fields. The following four hypotheses are offered to explain delayed functional loss in these patients: (1) A process independent of intraocular pressure is killing ganglion cells. (2) Unmeasured increases of pressure are killing ganglion cells. (3) The ganglion cells have a genetically determined hypersensitivity to intraocular pressure. (4) The ganglion cells have been rendered hypersensitive to intraocular pressure by irreversible damaging effects of previously increased intraocular pressures. The current state of knowledge does not permit the elimination of any of the four hypotheses. An additional hypothesis is that the final stage of ganglion cell death is mediated by apoptosis. If so, a potential new treatment for glaucoma would be to inhibit the apoptotic pathway.</description><subject>Adult</subject><subject>Apoptosis</subject><subject>Awards and Prizes</subject><subject>Biological and medical sciences</subject><subject>Cell Death</subject><subject>Female</subject><subject>Glaucoma - pathology</subject><subject>Glaucoma - physiopathology</subject><subject>Glaucoma and intraocular pressure</subject><subject>Humans</subject><subject>Intraocular Pressure</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Ophthalmology</subject><subject>Retinal Ganglion Cells - pathology</subject><subject>Societies, Medical</subject><subject>Vision Disorders - physiopathology</subject><subject>Visual Fields - physiology</subject><issn>0002-9394</issn><issn>1879-1891</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><recordid>eNqFkE9LwzAYh4Moc04_wqAHET1UkyZN2pPI3Oak4kE9hzR5C9H-mUmr7NvbbmNXTy_h9_zyJg9CU4JvCSb87g1jHIUpTdk1YTciZhEJoyM0JolIQ5Kk5BiND8gpOvP-sz9ywcQIjRJOsEjxGC0foVQbMMGiq3Vrm1qVQdZ4H9g6WJaq002lgmy1CubmVzkTPCv95Zs6eIGqcXaAQbedg3N0UqjSw8V-TtDHYv4-ewqz1-Vq9pCFmsVxGxYmzzU3pogNp6nKITWEgobY5AoDUZRQBn0gNOUsz7kwRRIDVzQpuNGG0Qm62t27ds13B76VlfUaylLV0HReigTjNCIDGO9A7frvOCjk2tlKuY0kWA4C5VagHOxIwuRWoIz63nS_oMsrMIfW3lifX-5z5bUqC6dqbf0Bo1jQKIp77H6HQS_jx4KTXluoNRjremPSNPafh_wBXBSM4w</recordid><startdate>19960501</startdate><enddate>19960501</enddate><creator>BRUBAKER, RICHARD F.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19960501</creationdate><title>Delayed Functional Loss in Glaucoma LII Edward Jackson Memorial Lecture</title><author>BRUBAKER, RICHARD F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-fdbbc6ddf5d639abe9d13ece5dba0e1a3134e39a7c364bb67df85e6a38f6dcd43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Adult</topic><topic>Apoptosis</topic><topic>Awards and Prizes</topic><topic>Biological and medical sciences</topic><topic>Cell Death</topic><topic>Female</topic><topic>Glaucoma - pathology</topic><topic>Glaucoma - physiopathology</topic><topic>Glaucoma and intraocular pressure</topic><topic>Humans</topic><topic>Intraocular Pressure</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Ophthalmology</topic><topic>Retinal Ganglion Cells - pathology</topic><topic>Societies, Medical</topic><topic>Vision Disorders - physiopathology</topic><topic>Visual Fields - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BRUBAKER, RICHARD F.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BRUBAKER, RICHARD F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Delayed Functional Loss in Glaucoma LII Edward Jackson Memorial Lecture</atitle><jtitle>American journal of ophthalmology</jtitle><addtitle>Am J Ophthalmol</addtitle><date>1996-05-01</date><risdate>1996</risdate><volume>121</volume><issue>5</issue><spage>473</spage><epage>483</epage><pages>473-483</pages><issn>0002-9394</issn><eissn>1879-1891</eissn><coden>AJOPAA</coden><abstract>This study is a systematic exploration of why some patients with glaucoma continue to lose visual field long after therapeutic normalization of their increased intraocular pressures. Three cases of glaucoma are described that had increased intraocular pressures and good initial visual fields. The following four hypotheses are offered to explain delayed functional loss in these patients: (1) A process independent of intraocular pressure is killing ganglion cells. (2) Unmeasured increases of pressure are killing ganglion cells. (3) The ganglion cells have a genetically determined hypersensitivity to intraocular pressure. (4) The ganglion cells have been rendered hypersensitive to intraocular pressure by irreversible damaging effects of previously increased intraocular pressures. The current state of knowledge does not permit the elimination of any of the four hypotheses. An additional hypothesis is that the final stage of ganglion cell death is mediated by apoptosis. If so, a potential new treatment for glaucoma would be to inhibit the apoptotic pathway.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>8610790</pmid><doi>10.1016/S0002-9394(14)75421-2</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9394
ispartof American journal of ophthalmology, 1996-05, Vol.121 (5), p.473-483
issn 0002-9394
1879-1891
language eng
recordid cdi_proquest_miscellaneous_78009214
source ScienceDirect Freedom Collection
subjects Adult
Apoptosis
Awards and Prizes
Biological and medical sciences
Cell Death
Female
Glaucoma - pathology
Glaucoma - physiopathology
Glaucoma and intraocular pressure
Humans
Intraocular Pressure
Male
Medical sciences
Middle Aged
Ophthalmology
Retinal Ganglion Cells - pathology
Societies, Medical
Vision Disorders - physiopathology
Visual Fields - physiology
title Delayed Functional Loss in Glaucoma LII Edward Jackson Memorial Lecture
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T18%3A00%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Delayed%20Functional%20Loss%20in%20Glaucoma%20LII%20Edward%20Jackson%20Memorial%20Lecture&rft.jtitle=American%20journal%20of%20ophthalmology&rft.au=BRUBAKER,%20RICHARD%20F.&rft.date=1996-05-01&rft.volume=121&rft.issue=5&rft.spage=473&rft.epage=483&rft.pages=473-483&rft.issn=0002-9394&rft.eissn=1879-1891&rft.coden=AJOPAA&rft_id=info:doi/10.1016/S0002-9394(14)75421-2&rft_dat=%3Cproquest_cross%3E78009214%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c455t-fdbbc6ddf5d639abe9d13ece5dba0e1a3134e39a7c364bb67df85e6a38f6dcd43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=78009214&rft_id=info:pmid/8610790&rfr_iscdi=true